磺胺甲噻二唑
磺胺甲噻二唑是一種磺胺類藥物,其INN名稱是「Sulfamethizole」。該藥物可用於治療由細菌感染引起的疾病等病症。該藥物在血液中的半衰期約為3-8小時,在大鼠體內的LD50(半致死量)為1.8564mol/kg。該藥物主要經肝代謝。[1][2]
臨床資料 | |
---|---|
AHFS/Drugs.com | Micromedex詳細消費者藥物信息 |
MedlinePlus | a682231 |
ATC碼 | |
藥物動力學數據 | |
血漿蛋白結合率 | 98–99% |
生物半衰期 | 3–8 hours |
識別資訊 | |
| |
CAS號 | 144-82-1 |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.129 |
化學資訊 | |
化學式 | C9H10N4O2S2 |
摩爾質量 | 270.333 g/mol |
3D模型(JSmol) | |
| |
|
參考文獻
拓展閱讀
- Ratanajamit C, Skriver M, Nørgaard M, Jepsen P, Schønheyder H, Sørensen H. Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.. J Antimicrob Chemother. 2003, 52 (5): 837–41. PMID 14519675. doi:10.1093/jac/dkg438.
- Kerrn M, Frimodt-Møller N, Espersen F. Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse Model. Antimicrob Agents Chemother. 2003, 47 (3): 1002–9. PMC 149286 . PMID 12604534. doi:10.1128/AAC.47.3.1002-1009.2003.
- Watanabe H, Hastings J. Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine. Biochim Biophys Acta. 1990, 1017 (3): 229–34. PMID 2372557. doi:10.1016/0005-2728(90)90189-B.
這是一篇與藥學相關的小作品。您可以透過編輯或修訂擴充其內容。 |